Insider trades
ADAR1 Partners, 10% Owner of Keros Therapeutics KROS, has filed 5 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $95.7M. The latest trade was on 25/10/15.
ADAR1 Partners
10% Owner
- Company
- Keros Therapeutics KROS
- First filing
- 24/08/12
- Trades
- 23 trades
- Buys / sales
- 5 / 3
- 12-month net buying
- −$95.7M
- Last trade
- 25/10/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
KROS | Open-market sale | 25/10/15 | 25/10/15 | 5,389,264 sh3 trades | $17.75avg. | $95,659,436 | −100.0% |
KROS | Open-market buy | 25/04/09 | 25/04/11 | 934,258 sh5 trades | $10.13avg. | $9,465,654.89 | +27.0% |
PVLA | Open-market buy | 24/08/09–24/08/12 | 24/08/12 | 6,000 sh3 trades | $15.39avg. | $92,310 | +66.2% |
